INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 72 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $266 | -73.4% | 480 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 480 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 480 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 480 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 480 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 480 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 480 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 480 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 480 | +42.9% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 336 | -3.7% | 0.00% | – |
| Q1 2016 | $2,000 | -89.5% | 349 | -85.1% | 0.00% | – |
| Q4 2015 | $19,000 | +533.3% | 2,337 | +593.5% | 0.00% | – |
| Q3 2015 | $3,000 | -88.5% | 337 | -85.5% | 0.00% | – |
| Q2 2015 | $26,000 | -13.3% | 2,326 | +6.8% | 0.00% | – |
| Q1 2015 | $30,000 | -18.9% | 2,177 | +0.2% | 0.00% | – |
| Q4 2014 | $37,000 | – | 2,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |